Senators Push Bipartisan Effort to List Drug Prices in Ads (1)

The HHS would have $1 million to force drug companies to display drug price information in ads thanks to a bipartisan funding amendment, but the jury is still out on whether that would lower prices.

Sen. Charles Grassley (R-Iowa) and Sen. Dick Durbin (D-Ill.) introduced an amendment July 26 for some Health and Human Services Department funding that would give the agency up to $1 million to regulate drug advertisements. The regulation requires direct-to-consumer drug advertisements to “include an appropriate disclosure of pricing information with respect to such drugs,” the amendment says.

It’s unclear what price the HHS would require ...